logo BDSP

Base documentaire


  1. Fulltext. The US economic and social costs of Alzheimer's disease revisited.

    Article - En anglais

    Fulltext.

    Objectives

    An earlier paper estimated the per-case and national incidence costs of Alzheimer's disease for 1983.

    This paper updates the estimates of costs per case to 1991 and presents new national prevalence estimates of the economic and social costs of the disease.

    Methods

    All data for the cost estimates were taken from published sources or provided by other researchers.

    Results

    At midrange values of the estimated cost and epidemiological parameters, the discounted (at 4%) direct and total costs fo Alzheiner's disease were $47 581 and $173 932 per case, respectively.

    The estimated 1991 national direct and total prevalence costs were $20.6 billion and $67.3 billion, respectively.

    Mots-clés Pascal : Démence Alzheimer, Analyse coût, Economie santé, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Homme, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Maladie dégénérative

    Mots-clés Pascal anglais : Alzheimer disease, Cost analysis, Health economy, Epidemiology, United States, North America, America, Human, Nervous system diseases, Central nervous system disease, Cerebral disorder, Degenerative disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 94-0590092

    Code Inist : 002B17G. Création : 09/06/1995.